PubMed

Protein methylation is required to maintain optimal HIV-1 infectivity.

Willemsen NM, Hitchen EM, Bodetti TJ, Apolloni A, Warrilow D, Piller SC, Harrich D.

Retrovirology. 2006 Dec 15;3:92.PMID: 17169163 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.

BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ.

J Hum Virol. 2000 Jan-Feb;3(1):6-15.PMID: 10774802 [PubMed - indexed for MEDLINE]Related articles

Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Shehu-Xhilaga M, Crowe SM, Mak J.

J Virol. 2001 Feb;75(4):1834-41.PMID: 11160682 [PubMed - indexed for MEDLINE]Related articlesFree article

Virion-targeted viral inactivation: new therapy against viral infection.

Okui N, Kitamura Y, Kobayashi N, Sakuma R, Ishikawa T, Kitamura T.

Mol Urol. 2001 Summer;5(2):59-66.PMID: 11690549 [PubMed - indexed for MEDLINE]Related articles

Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells.

Muthumani K, Montaner LJ, Ayyavoo V, Weiner DB.

DNA Cell Biol. 2000 Mar;19(3):179-88.PMID: 10749170 [PubMed - indexed for MEDLINE]Related articles

Analysis of human immunodeficiency virus type 1 containing HERV-K protease.

Padow M, Lai L, Fisher RJ, Zhou YC, Wu X, Kappes JC, Towler EM.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1973-80.PMID: 11153080 [PubMed - indexed for MEDLINE]Related articles

HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.

Yao XJ, Kobinger G, Dandache S, Rougeau N, Cohen E.

Gene Ther. 1999 Sep;6(9):1590-9.PMID: 10490769 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.

Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC.

Virology. 2004 Oct 10;328(1):36-44.PMID: 15380356 [PubMed - indexed for MEDLINE]Related articles

Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.

Schaeffer E, Soros VB, Greene WC.

J Virol. 2004 Feb;78(3):1375-83.PMID: 14722292 [PubMed - indexed for MEDLINE]Related articlesFree article

Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.

Xie B, Invernizzi CF, Richard S, Wainberg MA.

J Virol. 2007 Apr;81(8):4226-34. Epub 2007 Jan 31.PMID: 17267505 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).

Schafer EA, Venkatachari NJ, Ayyavoo V.

Antiviral Res. 2006 Dec;72(3):224-32. Epub 2006 Jul 7.PMID: 16889838 [PubMed - indexed for MEDLINE]Related articles

trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.

Saphire AC, Bobardt MD, Gallay PA.

J Virol. 2002 Mar;76(5):2255-62.PMID: 11836403 [PubMed - indexed for MEDLINE]Related articlesFree article

Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.

Poon B, Chang MA, Chen IS.

J Virol. 2007 Oct;81(19):10515-23. Epub 2007 Jul 25.PMID: 17652391 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiviral agent based on the non-structural protein targeting the maturation process of HIV-1: expression and susceptibility of chimeric Vpr as a substrate for cleavage by HIV-1 protease.

Serio D, Singh SP, Cartas MA, Weber IT, Harrison RW, Louis JM, Srinivasan A.

Protein Eng. 2000 Jun;13(6):431-6.PMID: 10877854 [PubMed - indexed for MEDLINE]Related articlesFree article

The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.

Gendron K, Dulude D, Lemay G, Ferbeyre G, Brakier-Gingras L.

Virology. 2005 Apr 10;334(2):342-52.PMID: 15780884 [PubMed - indexed for MEDLINE]Related articles

The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.

Wang J, Shackelford JM, Casella CR, Shivers DK, Rapaport EL, Liu B, Yu XF, Finkel TH.

Virology. 2007 Mar 15;359(2):243-52. Epub 2006 Oct 23.PMID: 17056089 [PubMed - indexed for MEDLINE]Related articlesFree article

Functional association between the nef gene product and gag-pol region of HIV-1.

Ono T, Iwatani Y, Nishimura A, Ishimoto A, Sakai H.

FEBS Lett. 2000 Jan 28;466(2-3):233-8.PMID: 10682834 [PubMed - indexed for MEDLINE]Related articles

Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.

Qiao H, McMillan JR.

FEBS Lett. 2007 Feb 6;581(3):535-40. Epub 2007 Jan 17.PMID: 17254575 [PubMed - indexed for MEDLINE]Related articles

Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.

Perugi F, Muriaux D, Ramirez BC, Chabani S, Decroly E, Darlix JL, Blot V, Pique C.

Mol Biol Cell. 2009 Jan;20(1):498-508. Epub 2008 Oct 22.PMID: 18946087 [PubMed - indexed for MEDLINE]Related articlesFree article

Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.

Singh SP, Tungaturthi P, Cartas M, Tomkowicz B, Rizvi TA, Khan SA, Kalyanaraman VS, Srinivasan A.

Virology. 2001 Apr 25;283(1):78-83.PMID: 11312664 [PubMed - indexed for MEDLINE]Related articles